These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7211256)

  • 21. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
    Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early factors associated with axonal loss after optic neuritis.
    Henderson AP; Altmann DR; Trip SA; Miszkiel KA; Schlottmann PG; Jones SJ; Garway-Heath DF; Plant GT; Miller DH
    Ann Neurol; 2011 Dec; 70(6):955-63. PubMed ID: 22190367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of static perimetry in subclinical optic neuritis in multiple sclerosis].
    Mauguière F; Perret-Magloire E
    Rev Neurol (Paris); 1983; 139(12):745-52. PubMed ID: 6665389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed visual perception and delayed visual evoked potentials in the spinal form of multiple sclerosis and in retrobulbar neuritis.
    Regan D; Milner BA; Heron JR
    Brain; 1976 Mar; 99(1):43-66. PubMed ID: 963530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study.
    Trauzettel-Klosinski S; Diener HC; Dietz K; Zrenner E
    Doc Ophthalmol; 1995-1996; 91(2):165-79. PubMed ID: 8813496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remitting multiple sclerosis.
    Behbehani R; Ahmed S; Al-Hashel J; Rousseff RT; Alroughani R
    Mult Scler Relat Disord; 2017 Feb; 12():15-19. PubMed ID: 28283099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential.
    Klistorner A; Chai Y; Leocani L; Albrecht P; Aktas O; Butzkueven H; Ziemssen T; Ziemssen F; Frederiksen J; Xu L; Cadavid D;
    CNS Drugs; 2018 Dec; 32(12):1159-1171. PubMed ID: 30267385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
    Di Maggio G; Santangelo R; Guerrieri S; Bianco M; Ferrari L; Medaglini S; Rodegher M; Colombo B; Moiola L; Chieffo R; Del Carro U; Martinelli V; Comi G; Leocani L
    Mult Scler; 2014 Sep; 20(10):1342-7. PubMed ID: 24591532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
    Grecescu M
    J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term prolongation of direct pupillary light reflex latency and P100 latency of pattern visual evoked potential in unilateral optic neuritis].
    Chin S; Suzuki Y; Ohashi T; Kase M
    Nippon Ganka Gakkai Zasshi; 1995 Feb; 99(2):226-31. PubMed ID: 7701996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests.
    van Diemen HA; Lanting P; Koetsier JC; Strijers RL; van Walbeek HK; Polman CH
    Clin Neurol Neurosurg; 1992; 94(3):191-5. PubMed ID: 1327607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demyelinating optic neuritis: clinical features and differential diagnosis.
    Francis DA
    Br J Hosp Med; 1991 Jun; 45(6):376-9. PubMed ID: 2070169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation of visual evoked potential delay to stimulation of central, nasal, and temporal regions of the macula in optic neuritis.
    Rinalduzzi S; Brusa A; Jones SJ
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):28-35. PubMed ID: 11118244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired color vision defects in retrobulbar neuritis.
    Griffin JF; Wray SH
    Am J Ophthalmol; 1978 Aug; 86(2):193-201. PubMed ID: 686121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Visual evoked potentials in reversal and motion-onset stimulation of visual fields in patients with retrobulbar neuritis].
    Kubová Z; Kuba M
    Cesk Oftalmol; 1993 Oct; 49(5):278-85. PubMed ID: 8221941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in visual evoked potential latencies following retrobulbar neuritis].
    Gruber H
    Klin Monbl Augenheilkd; 1990 Jul; 197(1):18-9. PubMed ID: 2395298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed and pseudodelayed visual evoked potentials in optic neuritis compared with long time echo-short tau inversion recovery magnetic resonance imaging of optic nerve.
    Onofrj M; Fulgente T; Thomas A; Gambi D; Melchionda D; Lopez L
    Electroencephalogr Clin Neurophysiol; 1996 Jul; 100(4):275-86. PubMed ID: 17441298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The visually evoked cortical potentials (VECPs) in optic neuritis (author's transl)].
    Wildberger H
    Klin Monbl Augenheilkd; 1976 Jan; 168(1):98-100. PubMed ID: 979038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.